nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—SLC6A3—nerve—multiple sclerosis	0.0168	0.0898	CbGeAlD
Dextroamphetamine—TAAR1—nervous system—multiple sclerosis	0.0147	0.0786	CbGeAlD
Dextroamphetamine—TAAR1—central nervous system—multiple sclerosis	0.0142	0.0757	CbGeAlD
Dextroamphetamine—SLC6A2—nerve—multiple sclerosis	0.0136	0.0725	CbGeAlD
Dextroamphetamine—SLC18A2—brainstem—multiple sclerosis	0.00955	0.051	CbGeAlD
Dextroamphetamine—SLC6A3—brainstem—multiple sclerosis	0.00722	0.0386	CbGeAlD
Dextroamphetamine—Pseudoephedrine—IL2—multiple sclerosis	0.00708	0.4	CrCbGaD
Dextroamphetamine—SLC18A2—medulla oblongata—multiple sclerosis	0.00666	0.0355	CbGeAlD
Dextroamphetamine—SLC18A2—midbrain—multiple sclerosis	0.00608	0.0325	CbGeAlD
Dextroamphetamine—SLC6A2—brainstem—multiple sclerosis	0.00583	0.0311	CbGeAlD
Dextroamphetamine—ADRA1A—brainstem—multiple sclerosis	0.00542	0.0289	CbGeAlD
Dextroamphetamine—ADRA1B—nervous system—multiple sclerosis	0.00505	0.027	CbGeAlD
Dextroamphetamine—SLC18A2—nervous system—multiple sclerosis	0.005	0.0267	CbGeAlD
Dextroamphetamine—ADRA1B—central nervous system—multiple sclerosis	0.00486	0.026	CbGeAlD
Dextroamphetamine—SLC18A2—central nervous system—multiple sclerosis	0.00482	0.0257	CbGeAlD
Dextroamphetamine—SLC18A2—cerebellum—multiple sclerosis	0.00471	0.0251	CbGeAlD
Dextroamphetamine—SLC6A3—midbrain—multiple sclerosis	0.0046	0.0246	CbGeAlD
Dextroamphetamine—SLC6A3—spinal cord—multiple sclerosis	0.00449	0.024	CbGeAlD
Dextroamphetamine—Nateglinide—SLC15A2—multiple sclerosis	0.0041	0.232	CrCbGaD
Dextroamphetamine—SLC6A2—medulla oblongata—multiple sclerosis	0.00406	0.0217	CbGeAlD
Dextroamphetamine—ADRA1B—brain—multiple sclerosis	0.00386	0.0206	CbGeAlD
Dextroamphetamine—SLC18A2—brain—multiple sclerosis	0.00382	0.0204	CbGeAlD
Dextroamphetamine—SLC6A3—nervous system—multiple sclerosis	0.00378	0.0202	CbGeAlD
Dextroamphetamine—SLC6A3—central nervous system—multiple sclerosis	0.00364	0.0195	CbGeAlD
Dextroamphetamine—SLC6A3—cerebellum—multiple sclerosis	0.00356	0.019	CbGeAlD
Dextroamphetamine—Ephedrine—BCHE—multiple sclerosis	0.00325	0.184	CrCbGaD
Dextroamphetamine—CYP2D6—brainstem—multiple sclerosis	0.00319	0.017	CbGeAlD
Dextroamphetamine—SLC6A2—nervous system—multiple sclerosis	0.00305	0.0163	CbGeAlD
Dextroamphetamine—SLC6A2—central nervous system—multiple sclerosis	0.00294	0.0157	CbGeAlD
Dextroamphetamine—SLC6A3—brain—multiple sclerosis	0.00289	0.0154	CbGeAlD
Dextroamphetamine—ADRA1A—nervous system—multiple sclerosis	0.00284	0.0152	CbGeAlD
Dextroamphetamine—ADRA1A—central nervous system—multiple sclerosis	0.00273	0.0146	CbGeAlD
Dextroamphetamine—ADRA1A—cerebellum—multiple sclerosis	0.00267	0.0143	CbGeAlD
Dextroamphetamine—Pseudoephedrine—TNF—multiple sclerosis	0.00239	0.135	CrCbGaD
Dextroamphetamine—SLC6A2—brain—multiple sclerosis	0.00233	0.0125	CbGeAlD
Dextroamphetamine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00229	0.00377	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Prednisolone—multiple sclerosis	0.00227	0.00375	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00224	0.0037	CcSEcCtD
Dextroamphetamine—Infection—Azathioprine—multiple sclerosis	0.00222	0.00366	CcSEcCtD
Dextroamphetamine—Urticaria—Cladribine—multiple sclerosis	0.00218	0.00359	CcSEcCtD
Dextroamphetamine—ADRA1A—brain—multiple sclerosis	0.00217	0.0116	CbGeAlD
Dextroamphetamine—Abdominal pain—Cladribine—multiple sclerosis	0.00217	0.00358	CcSEcCtD
Dextroamphetamine—Body temperature increased—Cladribine—multiple sclerosis	0.00217	0.00358	CcSEcCtD
Dextroamphetamine—Affect lability—Prednisone—multiple sclerosis	0.00215	0.00355	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Prednisone—multiple sclerosis	0.00214	0.00352	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.0021	0.00347	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.0021	0.00346	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00209	0.00345	CcSEcCtD
Dextroamphetamine—Irritability—Prednisone—multiple sclerosis	0.00209	0.00344	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00209	0.00344	CcSEcCtD
Dextroamphetamine—Mood swings—Prednisone—multiple sclerosis	0.00207	0.00342	CcSEcCtD
Dextroamphetamine—Sweating—Methylprednisolone—multiple sclerosis	0.00204	0.00337	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Cladribine—multiple sclerosis	0.00202	0.00333	CcSEcCtD
Dextroamphetamine—Asthenia—Cladribine—multiple sclerosis	0.00197	0.00325	CcSEcCtD
Dextroamphetamine—Weight decreased—Dexamethasone—multiple sclerosis	0.00196	0.00324	CcSEcCtD
Dextroamphetamine—Weight decreased—Betamethasone—multiple sclerosis	0.00196	0.00324	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00193	0.00318	CcSEcCtD
Dextroamphetamine—Convulsion—Mitoxantrone—multiple sclerosis	0.00191	0.00316	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.00191	0.00315	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.00191	0.00315	CcSEcCtD
Dextroamphetamine—Hypertension—Mitoxantrone—multiple sclerosis	0.00191	0.00315	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.0019	0.00313	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Betamethasone—multiple sclerosis	0.0019	0.00313	CcSEcCtD
Dextroamphetamine—Chest pain—Mitoxantrone—multiple sclerosis	0.00188	0.0031	CcSEcCtD
Dextroamphetamine—Diarrhoea—Cladribine—multiple sclerosis	0.00188	0.0031	CcSEcCtD
Dextroamphetamine—Anxiety—Mitoxantrone—multiple sclerosis	0.00187	0.00309	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.00187	0.00308	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00182	0.00301	CcSEcCtD
Dextroamphetamine—Dizziness—Cladribine—multiple sclerosis	0.00181	0.00299	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.0018	0.00297	CcSEcCtD
Dextroamphetamine—Infection—Mitoxantrone—multiple sclerosis	0.00179	0.00296	CcSEcCtD
Dextroamphetamine—Body temperature increased—Azathioprine—multiple sclerosis	0.00176	0.00291	CcSEcCtD
Dextroamphetamine—Abdominal pain—Azathioprine—multiple sclerosis	0.00176	0.00291	CcSEcCtD
Dextroamphetamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00176	0.0029	CcSEcCtD
Dextroamphetamine—Irritability—Methotrexate—multiple sclerosis	0.00174	0.00288	CcSEcCtD
Dextroamphetamine—Vomiting—Cladribine—multiple sclerosis	0.00174	0.00288	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00174	0.00288	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Prednisone—multiple sclerosis	0.00174	0.00287	CcSEcCtD
Dextroamphetamine—Mood swings—Methotrexate—multiple sclerosis	0.00173	0.00286	CcSEcCtD
Dextroamphetamine—Rash—Cladribine—multiple sclerosis	0.00173	0.00285	CcSEcCtD
Dextroamphetamine—Dermatitis—Cladribine—multiple sclerosis	0.00173	0.00285	CcSEcCtD
Dextroamphetamine—Anorexia—Mitoxantrone—multiple sclerosis	0.00172	0.00284	CcSEcCtD
Dextroamphetamine—Headache—Cladribine—multiple sclerosis	0.00172	0.00283	CcSEcCtD
Dextroamphetamine—Weight decreased—Prednisone—multiple sclerosis	0.00171	0.00282	CcSEcCtD
Dextroamphetamine—Depression—Prednisone—multiple sclerosis	0.00168	0.00277	CcSEcCtD
Dextroamphetamine—CYP2D6—nervous system—multiple sclerosis	0.00167	0.00892	CbGeAlD
Dextroamphetamine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00166	0.00274	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisolone—multiple sclerosis	0.00166	0.00273	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Prednisone—multiple sclerosis	0.00165	0.00273	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00165	0.00272	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00164	0.00271	CcSEcCtD
Dextroamphetamine—Nausea—Cladribine—multiple sclerosis	0.00163	0.00269	CcSEcCtD
Dextroamphetamine—CYP2D6—central nervous system—multiple sclerosis	0.00161	0.00859	CbGeAlD
Dextroamphetamine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00161	0.00265	CcSEcCtD
Dextroamphetamine—Somnolence—Mitoxantrone—multiple sclerosis	0.0016	0.00264	CcSEcCtD
Dextroamphetamine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00159	0.00262	CcSEcCtD
Dextroamphetamine—CYP2D6—cerebellum—multiple sclerosis	0.00157	0.0084	CbGeAlD
Dextroamphetamine—Convulsion—Prednisolone—multiple sclerosis	0.00157	0.00259	CcSEcCtD
Dextroamphetamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00157	0.00259	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisolone—multiple sclerosis	0.00157	0.00258	CcSEcCtD
Dextroamphetamine—Fatigue—Mitoxantrone—multiple sclerosis	0.00155	0.00256	CcSEcCtD
Dextroamphetamine—Constipation—Mitoxantrone—multiple sclerosis	0.00154	0.00254	CcSEcCtD
Dextroamphetamine—Diarrhoea—Azathioprine—multiple sclerosis	0.00153	0.00252	CcSEcCtD
Dextroamphetamine—Angioedema—Triamcinolone—multiple sclerosis	0.00152	0.00251	CcSEcCtD
Dextroamphetamine—Angioedema—Methylprednisolone—multiple sclerosis	0.00152	0.00251	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00148	0.00244	CcSEcCtD
Dextroamphetamine—Dizziness—Azathioprine—multiple sclerosis	0.00148	0.00243	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00147	0.00243	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00146	0.0024	CcSEcCtD
Dextroamphetamine—Convulsion—Triamcinolone—multiple sclerosis	0.00144	0.00238	CcSEcCtD
Dextroamphetamine—Tachycardia—Prednisolone—multiple sclerosis	0.00144	0.00238	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00144	0.00238	CcSEcCtD
Dextroamphetamine—Convulsion—Methylprednisolone—multiple sclerosis	0.00144	0.00238	CcSEcCtD
Dextroamphetamine—Hypertension—Triamcinolone—multiple sclerosis	0.00144	0.00237	CcSEcCtD
Dextroamphetamine—Hypertension—Methylprednisolone—multiple sclerosis	0.00144	0.00237	CcSEcCtD
Dextroamphetamine—Urticaria—Mitoxantrone—multiple sclerosis	0.00143	0.00236	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00143	0.00236	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00143	0.00235	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00143	0.00235	CcSEcCtD
Dextroamphetamine—Vomiting—Azathioprine—multiple sclerosis	0.00142	0.00234	CcSEcCtD
Dextroamphetamine—Anxiety—Methylprednisolone—multiple sclerosis	0.00141	0.00233	CcSEcCtD
Dextroamphetamine—Rash—Azathioprine—multiple sclerosis	0.00141	0.00232	CcSEcCtD
Dextroamphetamine—Dermatitis—Azathioprine—multiple sclerosis	0.00141	0.00232	CcSEcCtD
Dextroamphetamine—Depression—Methotrexate—multiple sclerosis	0.0014	0.00232	CcSEcCtD
Dextroamphetamine—Headache—Azathioprine—multiple sclerosis	0.0014	0.00231	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.0014	0.0023	CcSEcCtD
Dextroamphetamine—Dry mouth—Triamcinolone—multiple sclerosis	0.00139	0.00229	CcSEcCtD
Dextroamphetamine—Angioedema—Betamethasone—multiple sclerosis	0.00138	0.00228	CcSEcCtD
Dextroamphetamine—Angioedema—Dexamethasone—multiple sclerosis	0.00138	0.00228	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00136	0.00224	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00136	0.00224	CcSEcCtD
Dextroamphetamine—Infection—Triamcinolone—multiple sclerosis	0.00135	0.00223	CcSEcCtD
Dextroamphetamine—Sweating—Methotrexate—multiple sclerosis	0.00135	0.00223	CcSEcCtD
Dextroamphetamine—Infection—Methylprednisolone—multiple sclerosis	0.00135	0.00222	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisolone—multiple sclerosis	0.00134	0.00221	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00133	0.00219	CcSEcCtD
Dextroamphetamine—Tachycardia—Triamcinolone—multiple sclerosis	0.00133	0.00219	CcSEcCtD
Dextroamphetamine—Nausea—Azathioprine—multiple sclerosis	0.00133	0.00219	CcSEcCtD
Dextroamphetamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00133	0.00219	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00132	0.00217	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00131	0.00216	CcSEcCtD
Dextroamphetamine—Convulsion—Betamethasone—multiple sclerosis	0.00131	0.00216	CcSEcCtD
Dextroamphetamine—Convulsion—Dexamethasone—multiple sclerosis	0.00131	0.00216	CcSEcCtD
Dextroamphetamine—Hypertension—Betamethasone—multiple sclerosis	0.00131	0.00215	CcSEcCtD
Dextroamphetamine—Hypertension—Dexamethasone—multiple sclerosis	0.00131	0.00215	CcSEcCtD
Dextroamphetamine—Asthenia—Mitoxantrone—multiple sclerosis	0.00129	0.00213	CcSEcCtD
Dextroamphetamine—Anxiety—Betamethasone—multiple sclerosis	0.00128	0.00212	CcSEcCtD
Dextroamphetamine—Anxiety—Dexamethasone—multiple sclerosis	0.00128	0.00212	CcSEcCtD
Dextroamphetamine—CYP2D6—brain—multiple sclerosis	0.00128	0.00682	CbGeAlD
Dextroamphetamine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00123	0.00204	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00123	0.00204	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00123	0.00204	CcSEcCtD
Dextroamphetamine—Insomnia—Triamcinolone—multiple sclerosis	0.00123	0.00203	CcSEcCtD
Dextroamphetamine—Insomnia—Methylprednisolone—multiple sclerosis	0.00123	0.00203	CcSEcCtD
Dextroamphetamine—Infection—Dexamethasone—multiple sclerosis	0.00123	0.00202	CcSEcCtD
Dextroamphetamine—Infection—Betamethasone—multiple sclerosis	0.00123	0.00202	CcSEcCtD
Dextroamphetamine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00121	0.002	CcSEcCtD
Dextroamphetamine—Agitation—Prednisone—multiple sclerosis	0.00121	0.002	CcSEcCtD
Dextroamphetamine—Tachycardia—Dexamethasone—multiple sclerosis	0.0012	0.00199	CcSEcCtD
Dextroamphetamine—Tachycardia—Betamethasone—multiple sclerosis	0.0012	0.00199	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisone—multiple sclerosis	0.0012	0.00199	CcSEcCtD
Dextroamphetamine—Dyspepsia—Triamcinolone—multiple sclerosis	0.0012	0.00198	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Methotrexate—multiple sclerosis	0.0012	0.00197	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.0012	0.00197	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00119	0.00197	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00119	0.00197	CcSEcCtD
Dextroamphetamine—Anorexia—Dexamethasone—multiple sclerosis	0.00118	0.00194	CcSEcCtD
Dextroamphetamine—Anorexia—Betamethasone—multiple sclerosis	0.00118	0.00194	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisolone—multiple sclerosis	0.00118	0.00194	CcSEcCtD
Dextroamphetamine—Fatigue—Triamcinolone—multiple sclerosis	0.00117	0.00193	CcSEcCtD
Dextroamphetamine—Fatigue—Methylprednisolone—multiple sclerosis	0.00117	0.00193	CcSEcCtD
Dextroamphetamine—Vomiting—Mitoxantrone—multiple sclerosis	0.00115	0.00189	CcSEcCtD
Dextroamphetamine—Convulsion—Prednisone—multiple sclerosis	0.00114	0.00188	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisone—multiple sclerosis	0.00114	0.00188	CcSEcCtD
Dextroamphetamine—Rash—Mitoxantrone—multiple sclerosis	0.00114	0.00188	CcSEcCtD
Dextroamphetamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00114	0.00187	CcSEcCtD
Dextroamphetamine—Headache—Mitoxantrone—multiple sclerosis	0.00113	0.00186	CcSEcCtD
Dextroamphetamine—Anxiety—Prednisone—multiple sclerosis	0.00112	0.00184	CcSEcCtD
Dextroamphetamine—Insomnia—Betamethasone—multiple sclerosis	0.00112	0.00184	CcSEcCtD
Dextroamphetamine—Insomnia—Dexamethasone—multiple sclerosis	0.00112	0.00184	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00111	0.00183	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00109	0.0018	CcSEcCtD
Dextroamphetamine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00109	0.00179	CcSEcCtD
Dextroamphetamine—Dyspepsia—Betamethasone—multiple sclerosis	0.00109	0.00179	CcSEcCtD
Dextroamphetamine—Urticaria—Triamcinolone—multiple sclerosis	0.00108	0.00178	CcSEcCtD
Dextroamphetamine—Urticaria—Methylprednisolone—multiple sclerosis	0.00108	0.00178	CcSEcCtD
Dextroamphetamine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00108	0.00177	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisone—multiple sclerosis	0.00108	0.00177	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00107	0.00177	CcSEcCtD
Dextroamphetamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.00107	0.00177	CcSEcCtD
Dextroamphetamine—Decreased appetite—Betamethasone—multiple sclerosis	0.00107	0.00177	CcSEcCtD
Dextroamphetamine—Nausea—Mitoxantrone—multiple sclerosis	0.00107	0.00177	CcSEcCtD
Dextroamphetamine—Infection—Prednisone—multiple sclerosis	0.00107	0.00176	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00107	0.00176	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00107	0.00176	CcSEcCtD
Dextroamphetamine—Fatigue—Betamethasone—multiple sclerosis	0.00106	0.00176	CcSEcCtD
Dextroamphetamine—Fatigue—Dexamethasone—multiple sclerosis	0.00106	0.00176	CcSEcCtD
Dextroamphetamine—Tachycardia—Prednisone—multiple sclerosis	0.00105	0.00173	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.00104	0.00171	CcSEcCtD
Dextroamphetamine—Anorexia—Prednisone—multiple sclerosis	0.00102	0.00169	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00101	0.00167	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00101	0.00167	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.001	0.00165	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.001	0.00165	CcSEcCtD
Dextroamphetamine—Urticaria—Dexamethasone—multiple sclerosis	0.000981	0.00162	CcSEcCtD
Dextroamphetamine—Urticaria—Betamethasone—multiple sclerosis	0.000981	0.00162	CcSEcCtD
Dextroamphetamine—Dizziness—Prednisolone—multiple sclerosis	0.000978	0.00161	CcSEcCtD
Dextroamphetamine—Asthenia—Triamcinolone—multiple sclerosis	0.000976	0.00161	CcSEcCtD
Dextroamphetamine—Body temperature increased—Betamethasone—multiple sclerosis	0.000976	0.00161	CcSEcCtD
Dextroamphetamine—Abdominal pain—Betamethasone—multiple sclerosis	0.000976	0.00161	CcSEcCtD
Dextroamphetamine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000976	0.00161	CcSEcCtD
Dextroamphetamine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000976	0.00161	CcSEcCtD
Dextroamphetamine—Asthenia—Methylprednisolone—multiple sclerosis	0.000974	0.00161	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisone—multiple sclerosis	0.000972	0.0016	CcSEcCtD
Dextroamphetamine—Convulsion—Methotrexate—multiple sclerosis	0.000954	0.00157	CcSEcCtD
Dextroamphetamine—Dyspepsia—Prednisone—multiple sclerosis	0.000946	0.00156	CcSEcCtD
Dextroamphetamine—Chest pain—Methotrexate—multiple sclerosis	0.000937	0.00155	CcSEcCtD
Dextroamphetamine—Decreased appetite—Prednisone—multiple sclerosis	0.000935	0.00154	CcSEcCtD
Dextroamphetamine—Rash—Prednisolone—multiple sclerosis	0.000933	0.00154	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisolone—multiple sclerosis	0.000932	0.00154	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000929	0.00153	CcSEcCtD
Dextroamphetamine—Fatigue—Prednisone—multiple sclerosis	0.000927	0.00153	CcSEcCtD
Dextroamphetamine—Headache—Prednisolone—multiple sclerosis	0.000927	0.00153	CcSEcCtD
Dextroamphetamine—Constipation—Prednisone—multiple sclerosis	0.000919	0.00152	CcSEcCtD
Dextroamphetamine—Dizziness—Triamcinolone—multiple sclerosis	0.0009	0.00148	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000899	0.00148	CcSEcCtD
Dextroamphetamine—Dizziness—Methylprednisolone—multiple sclerosis	0.000898	0.00148	CcSEcCtD
Dextroamphetamine—Infection—Methotrexate—multiple sclerosis	0.000893	0.00147	CcSEcCtD
Dextroamphetamine—Asthenia—Dexamethasone—multiple sclerosis	0.000886	0.00146	CcSEcCtD
Dextroamphetamine—Asthenia—Betamethasone—multiple sclerosis	0.000886	0.00146	CcSEcCtD
Dextroamphetamine—Nateglinide—ALB—multiple sclerosis	0.000883	0.0498	CrCbGaD
Dextroamphetamine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000879	0.00145	CcSEcCtD
Dextroamphetamine—Nausea—Prednisolone—multiple sclerosis	0.000879	0.00145	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000869	0.00143	CcSEcCtD
Dextroamphetamine—Vomiting—Triamcinolone—multiple sclerosis	0.000865	0.00143	CcSEcCtD
Dextroamphetamine—Vomiting—Methylprednisolone—multiple sclerosis	0.000863	0.00142	CcSEcCtD
Dextroamphetamine—Rash—Triamcinolone—multiple sclerosis	0.000858	0.00141	CcSEcCtD
Dextroamphetamine—Dermatitis—Triamcinolone—multiple sclerosis	0.000857	0.00141	CcSEcCtD
Dextroamphetamine—Anorexia—Methotrexate—multiple sclerosis	0.000857	0.00141	CcSEcCtD
Dextroamphetamine—Rash—Methylprednisolone—multiple sclerosis	0.000856	0.00141	CcSEcCtD
Dextroamphetamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000855	0.00141	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisone—multiple sclerosis	0.000854	0.00141	CcSEcCtD
Dextroamphetamine—Headache—Triamcinolone—multiple sclerosis	0.000852	0.00141	CcSEcCtD
Dextroamphetamine—Headache—Methylprednisolone—multiple sclerosis	0.000851	0.0014	CcSEcCtD
Dextroamphetamine—Abdominal pain—Prednisone—multiple sclerosis	0.00085	0.0014	CcSEcCtD
Dextroamphetamine—Body temperature increased—Prednisone—multiple sclerosis	0.00085	0.0014	CcSEcCtD
Dextroamphetamine—Diarrhoea—Betamethasone—multiple sclerosis	0.000845	0.00139	CcSEcCtD
Dextroamphetamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000845	0.00139	CcSEcCtD
Dextroamphetamine—Dizziness—Betamethasone—multiple sclerosis	0.000816	0.00135	CcSEcCtD
Dextroamphetamine—Dizziness—Dexamethasone—multiple sclerosis	0.000816	0.00135	CcSEcCtD
Dextroamphetamine—Insomnia—Methotrexate—multiple sclerosis	0.000813	0.00134	CcSEcCtD
Dextroamphetamine—Nausea—Triamcinolone—multiple sclerosis	0.000808	0.00133	CcSEcCtD
Dextroamphetamine—Nausea—Methylprednisolone—multiple sclerosis	0.000806	0.00133	CcSEcCtD
Dextroamphetamine—Dyspnoea—Methotrexate—multiple sclerosis	0.000801	0.00132	CcSEcCtD
Dextroamphetamine—Somnolence—Methotrexate—multiple sclerosis	0.000799	0.00132	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000792	0.00131	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methotrexate—multiple sclerosis	0.000791	0.0013	CcSEcCtD
Dextroamphetamine—Vomiting—Betamethasone—multiple sclerosis	0.000785	0.00129	CcSEcCtD
Dextroamphetamine—Vomiting—Dexamethasone—multiple sclerosis	0.000785	0.00129	CcSEcCtD
Dextroamphetamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000781	0.00129	CcSEcCtD
Dextroamphetamine—Rash—Betamethasone—multiple sclerosis	0.000778	0.00128	CcSEcCtD
Dextroamphetamine—Rash—Dexamethasone—multiple sclerosis	0.000778	0.00128	CcSEcCtD
Dextroamphetamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000778	0.00128	CcSEcCtD
Dextroamphetamine—Dermatitis—Betamethasone—multiple sclerosis	0.000778	0.00128	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000776	0.00128	CcSEcCtD
Dextroamphetamine—Fatigue—Methotrexate—multiple sclerosis	0.000775	0.00128	CcSEcCtD
Dextroamphetamine—Headache—Dexamethasone—multiple sclerosis	0.000773	0.00128	CcSEcCtD
Dextroamphetamine—Headache—Betamethasone—multiple sclerosis	0.000773	0.00128	CcSEcCtD
Dextroamphetamine—Asthenia—Prednisone—multiple sclerosis	0.000771	0.00127	CcSEcCtD
Dextroamphetamine—Diarrhoea—Prednisone—multiple sclerosis	0.000736	0.00121	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000735	0.00121	CcSEcCtD
Dextroamphetamine—Nausea—Betamethasone—multiple sclerosis	0.000733	0.00121	CcSEcCtD
Dextroamphetamine—Nausea—Dexamethasone—multiple sclerosis	0.000733	0.00121	CcSEcCtD
Dextroamphetamine—Urticaria—Methotrexate—multiple sclerosis	0.000714	0.00118	CcSEcCtD
Dextroamphetamine—Dizziness—Prednisone—multiple sclerosis	0.000711	0.00117	CcSEcCtD
Dextroamphetamine—Body temperature increased—Methotrexate—multiple sclerosis	0.00071	0.00117	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methotrexate—multiple sclerosis	0.00071	0.00117	CcSEcCtD
Dextroamphetamine—Vomiting—Prednisone—multiple sclerosis	0.000684	0.00113	CcSEcCtD
Dextroamphetamine—Rash—Prednisone—multiple sclerosis	0.000678	0.00112	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisone—multiple sclerosis	0.000677	0.00112	CcSEcCtD
Dextroamphetamine—Headache—Prednisone—multiple sclerosis	0.000674	0.00111	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000662	0.00109	CcSEcCtD
Dextroamphetamine—Asthenia—Methotrexate—multiple sclerosis	0.000645	0.00106	CcSEcCtD
Dextroamphetamine—Nausea—Prednisone—multiple sclerosis	0.000639	0.00105	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000615	0.00101	CcSEcCtD
Dextroamphetamine—Dizziness—Methotrexate—multiple sclerosis	0.000594	0.00098	CcSEcCtD
Dextroamphetamine—Vomiting—Methotrexate—multiple sclerosis	0.000571	0.000942	CcSEcCtD
Dextroamphetamine—Rash—Methotrexate—multiple sclerosis	0.000567	0.000934	CcSEcCtD
Dextroamphetamine—Dermatitis—Methotrexate—multiple sclerosis	0.000566	0.000934	CcSEcCtD
Dextroamphetamine—Headache—Methotrexate—multiple sclerosis	0.000563	0.000928	CcSEcCtD
Dextroamphetamine—Nausea—Methotrexate—multiple sclerosis	0.000534	0.00088	CcSEcCtD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000384	0.00203	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000383	0.00203	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCR1—multiple sclerosis	0.000378	0.002	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL13—multiple sclerosis	0.000378	0.002	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000373	0.00198	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00037	0.00196	CbGpPWpGaD
Dextroamphetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000369	0.00196	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000365	0.00194	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL3—multiple sclerosis	0.000363	0.00192	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00036	0.00191	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000358	0.0019	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000353	0.00187	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000353	0.00187	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000351	0.00186	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000351	0.00186	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PTGER4—multiple sclerosis	0.00035	0.00185	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000344	0.00182	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PGR—multiple sclerosis	0.000344	0.00182	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00034	0.0018	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCR3—multiple sclerosis	0.000338	0.00179	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CD28—multiple sclerosis	0.000334	0.00177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000332	0.00176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000329	0.00174	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCR2—multiple sclerosis	0.000328	0.00174	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000326	0.00173	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00032	0.00169	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000311	0.00165	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000308	0.00163	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CNR1—multiple sclerosis	0.000303	0.00161	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL3—multiple sclerosis	0.000303	0.00161	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000299	0.00158	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000296	0.00157	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—S1PR1—multiple sclerosis	0.000296	0.00157	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000295	0.00156	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—PTGER4—multiple sclerosis	0.000292	0.00155	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00029	0.00153	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000282	0.0015	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCR3—multiple sclerosis	0.000282	0.00149	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—POMC—multiple sclerosis	0.00028	0.00148	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—RGS1—multiple sclerosis	0.000277	0.00147	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCR2—multiple sclerosis	0.000274	0.00145	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000274	0.00145	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCL10—multiple sclerosis	0.000273	0.00145	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000271	0.00143	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL3—multiple sclerosis	0.000269	0.00143	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000266	0.00141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—S1PR1—multiple sclerosis	0.000263	0.00139	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GPR65—multiple sclerosis	0.000263	0.00139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—PTGER4—multiple sclerosis	0.000259	0.00137	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000257	0.00136	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CNR1—multiple sclerosis	0.000253	0.00134	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RGS1—multiple sclerosis	0.000252	0.00133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCR3—multiple sclerosis	0.00025	0.00133	CbGpPWpGaD
Dextroamphetamine—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	0.000249	0.00132	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000249	0.00132	CbGpPWpGaD
Dextroamphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000248	0.00132	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000246	0.0013	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCR2—multiple sclerosis	0.000243	0.00129	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00024	0.00127	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR1—multiple sclerosis	0.00024	0.00127	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00024	0.00127	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CD86—multiple sclerosis	0.000239	0.00126	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GPR65—multiple sclerosis	0.000239	0.00126	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL5—multiple sclerosis	0.000235	0.00125	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000233	0.00124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000232	0.00123	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LINGO1—multiple sclerosis	0.000231	0.00122	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000229	0.00121	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000228	0.00121	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL10—multiple sclerosis	0.000228	0.00121	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CNR1—multiple sclerosis	0.000225	0.00119	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RGS1—multiple sclerosis	0.000224	0.00119	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	0.000221	0.00117	CbGpPWpGaD
Dextroamphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.00022	0.00117	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL13—multiple sclerosis	0.000218	0.00116	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR1—multiple sclerosis	0.000218	0.00116	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SPP1—multiple sclerosis	0.000218	0.00115	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000217	0.00115	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—MAPK1—multiple sclerosis	0.000216	0.00115	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000213	0.00113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000213	0.00113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GPR65—multiple sclerosis	0.000212	0.00112	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCR5—multiple sclerosis	0.000212	0.00112	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL2RA—multiple sclerosis	0.000209	0.00111	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL2—multiple sclerosis	0.000207	0.0011	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000206	0.00109	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LINGO1—multiple sclerosis	0.000205	0.00109	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000202	0.00107	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TAGAP—multiple sclerosis	0.0002	0.00106	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL5—multiple sclerosis	0.000196	0.00104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR1—multiple sclerosis	0.000194	0.00103	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000194	0.00103	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000193	0.00102	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—APOE—multiple sclerosis	0.000193	0.00102	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000188	0.000994	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000181	0.000961	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TAGAP—multiple sclerosis	0.000178	0.000942	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000177	0.00094	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCR5—multiple sclerosis	0.000177	0.000936	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—S1PR1—multiple sclerosis	0.000175	0.000927	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL5—multiple sclerosis	0.000174	0.000923	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CD80—multiple sclerosis	0.000174	0.000923	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GPC5—multiple sclerosis	0.00017	0.000902	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SRM—multiple sclerosis	0.00017	0.0009	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000168	0.000892	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—POMC—multiple sclerosis	0.000165	0.000877	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000165	0.000874	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCL2—multiple sclerosis	0.000162	0.000858	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000161	0.000853	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000159	0.000844	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000158	0.000839	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000158	0.000835	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	0.000157	0.000834	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000157	0.000831	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL3—multiple sclerosis	0.000156	0.000824	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000155	0.000823	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR2—multiple sclerosis	0.000155	0.000821	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	0.000151	0.000801	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTGER4—multiple sclerosis	0.00015	0.000793	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RGS1—multiple sclerosis	0.000149	0.000788	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TYK2—multiple sclerosis	0.000147	0.000779	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000146	0.000776	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCR3—multiple sclerosis	0.000145	0.000766	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CNR1—multiple sclerosis	0.000143	0.000758	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000141	0.000749	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GPR65—multiple sclerosis	0.000141	0.000747	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR2—multiple sclerosis	0.000141	0.000745	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000138	0.000734	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000138	0.000732	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—POMC—multiple sclerosis	0.000138	0.000732	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000138	0.000729	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CCL2—multiple sclerosis	0.000135	0.000716	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000133	0.000705	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	0.000132	0.0007	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CNR1—multiple sclerosis	0.00013	0.000688	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	0.000129	0.000684	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR1—multiple sclerosis	0.000129	0.000683	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL13—multiple sclerosis	0.000129	0.000683	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000129	0.000682	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000128	0.000681	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000127	0.000673	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000126	0.000669	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	0.000125	0.000664	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000125	0.000662	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000123	0.000652	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	0.000123	0.00065	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL2—multiple sclerosis	0.000122	0.000648	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL6—multiple sclerosis	0.000122	0.000645	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	0.00012	0.000636	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	0.00012	0.000634	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	0.00012	0.000634	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000117	0.000619	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MMP9—multiple sclerosis	0.000116	0.000613	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	0.000115	0.000611	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000115	0.000607	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	0.000115	0.000607	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000114	0.000606	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000112	0.000593	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000111	0.000587	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPC5—multiple sclerosis	0.000109	0.00058	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000106	0.000564	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000104	0.00055	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STAT3—multiple sclerosis	0.000103	0.000545	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	0.000101	0.000533	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	9.98e-05	0.000529	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	9.84e-05	0.000522	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	9.84e-05	0.000521	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MYC—multiple sclerosis	9.56e-05	0.000507	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TGFB1—multiple sclerosis	9.54e-05	0.000506	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	9.45e-05	0.000501	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MAPK1—multiple sclerosis	9.35e-05	0.000496	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	9.19e-05	0.000487	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—RRM1—multiple sclerosis	9.07e-05	0.000481	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	9.06e-05	0.00048	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	8.94e-05	0.000474	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	8.93e-05	0.000473	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	8.86e-05	0.00047	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	8.84e-05	0.000469	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	8.74e-05	0.000463	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	8.71e-05	0.000462	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	8.54e-05	0.000453	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	8.46e-05	0.000448	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	8.31e-05	0.00044	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	8.16e-05	0.000432	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	8.05e-05	0.000427	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	7.93e-05	0.00042	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	7.85e-05	0.000416	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	7.8e-05	0.000413	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	7.74e-05	0.00041	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	7.67e-05	0.000406	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	7.59e-05	0.000402	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	7.52e-05	0.000398	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	7.38e-05	0.000391	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—multiple sclerosis	7.19e-05	0.000381	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	7.08e-05	0.000375	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	6.93e-05	0.000367	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	6.93e-05	0.000367	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	6.9e-05	0.000366	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	6.81e-05	0.000361	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	6.29e-05	0.000334	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	6.29e-05	0.000333	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	6.16e-05	0.000326	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	6.13e-05	0.000325	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	6.04e-05	0.00032	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	5.94e-05	0.000315	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	5.77e-05	0.000306	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	5.59e-05	0.000296	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	5.5e-05	0.000292	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	5.36e-05	0.000284	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	5.35e-05	0.000284	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	5.28e-05	0.00028	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	5.28e-05	0.00028	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	5.24e-05	0.000278	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.21e-05	0.000276	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	5.12e-05	0.000271	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	4.89e-05	0.000259	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	4.87e-05	0.000258	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	4.76e-05	0.000252	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	4.69e-05	0.000248	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	4.65e-05	0.000247	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	4.4e-05	0.000233	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	4.33e-05	0.000229	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	4.18e-05	0.000222	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	4.09e-05	0.000217	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	4.01e-05	0.000212	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	3.91e-05	0.000207	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	3.72e-05	0.000197	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	3.72e-05	0.000197	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	3.64e-05	0.000193	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	3.56e-05	0.000189	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	3.3e-05	0.000175	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOE—multiple sclerosis	3.13e-05	0.000166	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	3.09e-05	0.000164	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	3.08e-05	0.000163	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	2.93e-05	0.000155	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	2.75e-05	0.000146	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	2.73e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—multiple sclerosis	2.69e-05	0.000143	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	2.6e-05	0.000138	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	2.6e-05	0.000138	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—multiple sclerosis	2.45e-05	0.00013	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	2.42e-05	0.000128	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	2.41e-05	0.000128	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	2.37e-05	0.000125	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	2.31e-05	0.000123	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	2.15e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	2.14e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	2.1e-05	0.000111	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	1.82e-05	9.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.62e-05	8.56e-05	CbGpPWpGaD
